SCHEMBL5147449

SCHEMBL5147449

CCN(CC)CCOc1ccc2sc(-c3nc(NCCN4C(=O)NC(C)(C)C4=O)ncc3Br)cc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.38
ALOX15 P16050 1/20 0.36
LMNA P02545 4/20 0.35
PLA2G7 Q13093 1/20 0.35
ALDH1A1 P00352 4/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
SRC P12931 3/20 0.34
WEE1 P30291 2/20 0.34
HSD17B10 Q99714 1/20 0.34
FGFR1 P11362 2/20 0.33
FGFR2 P21802 2/20 0.33
FGFR4 P22455 2/20 0.33
FGFR3 P22607 2/20 0.33
CHEK1 O14757 1/20 0.33
RIPK2 O43353 1/20 0.33
JAK2 O60674 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5148348 0.93 GAA (0.37) GAAALOX15LMNAPLA2G7ALDH1A1
SCHEMBL5145975 0.90 ALOX15 (0.37) GAAALOX15LMNAPLA2G7ALDH1A1
SCHEMBL5148335 0.88 PDE3B (0.36) GAAALOX15LMNAPLA2G7ALDH1A1
SCHEMBL2983650 0.88 SRC (0.34) LMNAHTTSRCWEE1FGFR1
SCHEMBL5149190 0.88 ALOX15 (0.38) GAAALOX15LMNAPLA2G7ALDH1A1
SCHEMBL5147425 0.85 AURKB (0.38) GAAALOX15LMNAPLA2G7ALDH1A1
SCHEMBL5147313 0.83 ALDH1A1 (0.35) LMNAPLA2G7ALDH1A1SMN1; SMN2MAPT
SCHEMBL5147498 0.82 ALDH1A1 (0.36) GAAALOX15LMNAPLA2G7ALDH1A1
SCHEMBL5147380 0.82 ALDH1A1 (0.40) GAALMNAALDH1A1SMN1; SMN2MAPT
SCHEMBL5182068 0.82 MERTK (0.34) ALOX15LMNAALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP claimed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO claimed
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed